US Patent Issued to MILTENYI BIOTEC on July 22 for "Adapter-based retroviral vector system for the selective transduction of target cells" (German Inventors)

ALEXANDRIA, Va., July 23 -- United States Patent no. 12,365,916, issued on July 22, was assigned to MILTENYI BIOTEC B.V. & Co. KG (Bergisch Gladbach, Germany).

"Adapter-based retroviral vector system for the selective transduction of target cells" was invented by Thomas Schaser (Rosrath, Germany), Nicole Cordes (Cologne, Germany), Joerg Mittelstaet (Cologne, Germany) and Andrew Kaiser (Rosrath, Germany).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides a composition comprising i) a pseudotyped retroviral vector particle or virus-like particle thereof comprising a) one envelope protein with antigen-binding activity, wherein said envelope protein is a recombinant protein that does no...